Clinical trials
Phase 2 Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Terminated | 18 |
| Recruiting | 15 |
| Unknown status | 8 |
| Active, not recruiting | 5 |
| Withdrawn | 5 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| National Cancer Institute (NCI) | 6 |
| Masonic Cancer Center, University of Minnesota | 5 |
| City of Hope Medical Center | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| The Lymphoma Academic Research Organisation | 3 |
| Celgene | 2 |
| Dana-Farber Cancer Institute | 2 |
| Fondazione Italiana Linfomi - ETS | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 94 |
| Lymphoma | 21 |
| Lymphoma, Non-Hodgkin | 18 |
| Lymphoma, T-Cell, Peripheral | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Lymphoma, T-Cell, Cutaneous | 13 |
| Lymphoma, B-Cell | 12 |
| Lymphoma, Large B-Cell, Diffuse | 12 |
| Lymphoma, Large-Cell, Anaplastic | 12 |
| Lymphoma, Mantle-Cell | 12 |
Trials
Showing 26 to 50 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.